147 related articles for article (PubMed ID: 23382335)
1. Impact of heart rate on central hemodynamics and stroke: a meta-analysis of β-blocker trials.
Ding FH; Li Y; Li LH; Wang JG
Am J Hypertens; 2013 Jan; 26(1):118-25. PubMed ID: 23382335
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of randomized controlled trials assessing the impact of beta-blockers on arterial stiffness, peripheral blood pressure and heart rate.
Niu W; Qi Y
Int J Cardiol; 2016 Sep; 218():109-117. PubMed ID: 27232921
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
Shahin Y; Khan JA; Samuel N; Chetter I
Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
5. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.
Shahin Y; Khan JA; Chetter I
Atherosclerosis; 2012 Mar; 221(1):18-33. PubMed ID: 22209214
[TBL] [Abstract][Full Text] [Related]
7. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
[TBL] [Abstract][Full Text] [Related]
8. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
[TBL] [Abstract][Full Text] [Related]
9. Office management of hypertension in older persons.
Aronow WS
Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
11. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
Williams B; Lacy PS;
J Am Coll Cardiol; 2009 Aug; 54(8):705-13. PubMed ID: 19679248
[TBL] [Abstract][Full Text] [Related]
12. Effects of β-Blockers With and Without Vasodilating Properties on Central Blood Pressure: Systematic Review and Meta-Analysis of Randomized Trials in Hypertension.
Pucci G; Ranalli MG; Battista F; Schillaci G
Hypertension; 2016 Feb; 67(2):316-24. PubMed ID: 26628678
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
14. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Jul; 33(7):1321-41. PubMed ID: 26039526
[TBL] [Abstract][Full Text] [Related]
15. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
Law MR; Wald NJ; Morris JK; Jordan RE
BMJ; 2003 Jun; 326(7404):1427. PubMed ID: 12829555
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.
McAlister FA;
Eur Heart J; 2012 Feb; 33(4):505-14. PubMed ID: 22041554
[TBL] [Abstract][Full Text] [Related]
17. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
18. Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials.
Tropeano AI; Saleh N; Hawajri N; Macquin-Mavier I; Maison P
Fundam Clin Pharmacol; 2011 Jun; 25(3):395-404. PubMed ID: 20584209
[TBL] [Abstract][Full Text] [Related]
19. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
Basile J
J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
[No Abstract] [Full Text] [Related]
20. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
